Anson Funds Management’s Biohaven BHVN Stock Holding History

Anson Funds Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-667,381	Closed	-$7.53M	–	134
2025 Q4	$7.53M	Buy	+667,381	New	+$8.27M	0.71%	35

Other funds holding BHVN

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $242M AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Anson Funds Management's BHVN Position: Q1 2026 in Review

Anson Funds Management sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 667,381 shares — an estimated $7.53M sold.

Anson Funds Management first reported a position in BHVN in Q4 2025 and held it in 1 quarter. The position peaked at $7.53M in Q4 2025. 277 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Anson Funds Management reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
Anson Funds Management sold 667,381 Biohaven shares in Q1 2026, an estimated $7.53M.
Anson Funds Management first reported a position in Biohaven in Q4 2025 and held it in 1 quarter.
Anson Funds Management's Biohaven position peaked at $7.53M in Q4 2025.
277 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Anson Funds Management's 13F filing for Q1 2026, filed 14 May 2026.